ReShape Lifesciences | 8-K:重大事件
ReShape Lifesciences | 10-Q:季度报表
ReShape Lifesciences | S-3:特定交易注册声明
ReShape Lifesciences | 8-K:重大事件
ReShape Lifesciences | 8-K:重大事件
ReShape Lifesciences | 8-K:重大事件
ReShape Lifesciences | 10-K:年度报表
ReShape Lifesciences | 8-K:重大事件
ReShape Lifesciences | DEF 14A:股东委托书决议
ReShape Lifesciences | 8-K:重大事件
ReShape Lifesciences | SC 13G:超过5%持股股东披露文件-Yair Schneid(10.525%)
ReShape Lifesciences | 3:首次持股声明-股东 Schneid Yair
ReShape Lifesciences | PRE 14A:并购重组委托声明
ReShape Lifesciences | 8-K:重大事件
ReShape Lifesciences:2023财年三季报
ReShape Lifesciences | 8-K:重大事件
ReShape Lifesciences | 4:持股变动声明-首席财务官 STANKOVICH THOMAS
ReShape Lifesciences | 8-K:重大事件
ReShape Lifesciences | 8-K:重大事件
ReShape Lifesciences | 424B4:募资说明书
暂无数据